ChemInform Abstract: Discovery, Oral Pharmacokinetics and in vivo Efficacy of a Highly Selective 5-HT4 Receptor Agonist: Clinical Compound TD-2749

ChemInform Abstract: Discovery, Oral Pharmacokinetics and in vivo Efficacy of a Highly Selective 5-HT4 Receptor Agonist: Clinical Compound TD-2749

Application of the previously reported multivalent approach to drug discovery towards 5‐HT4 receptor agonists results in the identification of (I), which is selected as a development candidate.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:ChemInform 2012-11, Vol.43 (46), p.no-no
Hauptverfasser: Long, Daniel D., ., et al
Format: Artikel
Sprache:eng
Schlagworte:
pyridine derivatives with bridges
receptor binding activity
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Application of the previously reported multivalent approach to drug discovery towards 5‐HT4 receptor agonists results in the identification of (I), which is selected as a development candidate.
ISSN:0931-7597
1522-2667
DOI:10.1002/chin.201246179